Back
Speaker illustration

Ms Danielle Medina-Hernandez

Spanish National Centre for Cardiovascular Research, Madrid (Spain)

Presentations

Anthracycline cardiotoxicity is associated with high energy-consuming myosin heads conformation: a novel therapeutic target

Event: HFA Winter Research Meeting on Translational Heart Failure 2025

Topic: Cardiomyopathies

Session: Young Investigator Award Poster Session

Access
Like
Thumbnail

SGLT2 inhibitor empagliflozin prevents anthracycline-induced cardiotoxicity in a large-animal model

Event: ESC Congress 2024

Topic: Heart Failure

Session: Novel targets against myocardial damage

Access
Like
Thumbnail

Effect of SGLT2i empagliflozin on left ventricular and mitochondrial function in a porcine model of anthracycline-induced cardiotoxicity

Event: Heart Failure 2023

Topic: Cardiotoxicity of Drugs and Other Therapies

Session: ePosters in chronic heart failure - pathophysiology and mechanisms 1

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources